vs
Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and SIMMONS FIRST NATIONAL CORP (SFNC). Click either name above to swap in a different company.
HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $197.3M, roughly 1.4× SIMMONS FIRST NATIONAL CORP). On growth, SIMMONS FIRST NATIONAL CORP posted the faster year-over-year revenue change (19.6% vs -16.5%). SIMMONS FIRST NATIONAL CORP produced more free cash flow last quarter ($411.4M vs $3.4M).
HUTCHMED (China) LtdHCMEarnings & Financial Report
HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.
Simmons Bank is a bank with operations in Arkansas, Kansas, Missouri, Oklahoma, Tennessee, and Texas. It is the primary subsidiary of Simmons First National Corporation, a bank holding company.
HCM vs SFNC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $270.8M | $197.3M |
| Net Profit | $2.0M | — |
| Gross Margin | 37.7% | — |
| Operating Margin | -13.2% | — |
| Net Margin | 0.7% | — |
| Revenue YoY | -16.5% | 19.6% |
| Net Profit YoY | -83.6% | — |
| EPS (diluted) | $0.00 | $0.36 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $270.8M | $197.3M | ||
| Q3 25 | — | $186.7M | ||
| Q2 25 | $277.7M | $214.2M | ||
| Q1 25 | $324.5M | $209.6M | ||
| Q4 24 | — | $208.5M | ||
| Q3 24 | — | $174.8M | ||
| Q2 24 | $305.7M | $197.2M | ||
| Q1 24 | — | $195.1M |
| Q4 25 | $2.0M | — | ||
| Q3 25 | — | $-562.8M | ||
| Q2 25 | $455.0M | $54.8M | ||
| Q1 25 | $11.9M | $32.4M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $24.7M | ||
| Q2 24 | $25.8M | $40.8M | ||
| Q1 24 | — | $38.9M |
| Q4 25 | 37.7% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 48.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 41.1% | — | ||
| Q1 24 | — | — |
| Q4 25 | -13.2% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -1.3% | — | ||
| Q1 25 | -5.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -9.0% | — | ||
| Q1 24 | — | — |
| Q4 25 | 0.7% | — | ||
| Q3 25 | — | -301.5% | ||
| Q2 25 | 163.8% | 25.6% | ||
| Q1 25 | 3.7% | 15.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 14.1% | ||
| Q2 24 | 8.4% | 20.7% | ||
| Q1 24 | — | 19.9% |
| Q4 25 | $0.00 | $0.36 | ||
| Q3 25 | — | $-4.00 | ||
| Q2 25 | $0.52 | $0.43 | ||
| Q1 25 | $0.01 | $0.26 | ||
| Q4 24 | — | $0.38 | ||
| Q3 24 | — | $0.20 | ||
| Q2 24 | $0.03 | $0.32 | ||
| Q1 24 | — | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.4B | — |
| Total DebtLower is stronger | $93.2M | $620.0M |
| Stockholders' EquityBook value | $1.2B | $3.4B |
| Total Assets | $1.8B | $24.5B |
| Debt / EquityLower = less leverage | 0.08× | 0.18× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.4B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $1.4B | — | ||
| Q1 25 | $836.1M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $802.5M | — | ||
| Q1 24 | — | — |
| Q4 25 | $93.2M | $620.0M | ||
| Q3 25 | — | $667.8M | ||
| Q2 25 | $93.4M | $1.0B | ||
| Q1 25 | $82.8M | $1.3B | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | — | $1.4B | ||
| Q2 24 | $82.1M | $1.7B | ||
| Q1 24 | — | $1.2B |
| Q4 25 | $1.2B | $3.4B | ||
| Q3 25 | — | $3.4B | ||
| Q2 25 | $1.2B | $3.5B | ||
| Q1 25 | $759.9M | $3.5B | ||
| Q4 24 | — | $3.5B | ||
| Q3 24 | — | $3.5B | ||
| Q2 24 | $740.1M | $3.5B | ||
| Q1 24 | — | $3.4B |
| Q4 25 | $1.8B | $24.5B | ||
| Q3 25 | — | $24.2B | ||
| Q2 25 | $1.8B | $26.7B | ||
| Q1 25 | $1.3B | $26.8B | ||
| Q4 24 | — | $26.9B | ||
| Q3 24 | — | $27.3B | ||
| Q2 24 | $1.3B | $27.4B | ||
| Q1 24 | — | $27.4B |
| Q4 25 | 0.08× | 0.18× | ||
| Q3 25 | — | 0.20× | ||
| Q2 25 | 0.08× | 0.28× | ||
| Q1 25 | 0.11× | 0.35× | ||
| Q4 24 | — | 0.32× | ||
| Q3 24 | — | 0.40× | ||
| Q2 24 | 0.11× | 0.50× | ||
| Q1 24 | — | 0.36× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.2M | $449.5M |
| Free Cash FlowOCF − Capex | $3.4M | $411.4M |
| FCF MarginFCF / Revenue | 1.2% | 208.5% |
| Capex IntensityCapex / Revenue | 1.8% | 19.3% |
| Cash ConversionOCF / Net Profit | 4.21× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-96.2M | $717.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.2M | $449.5M | ||
| Q3 25 | — | $223.4M | ||
| Q2 25 | $-72.9M | $77.6M | ||
| Q1 25 | $40.3M | $32.8M | ||
| Q4 24 | — | $425.9M | ||
| Q3 24 | — | $199.4M | ||
| Q2 24 | $-39.8M | $86.1M | ||
| Q1 24 | — | $57.6M |
| Q4 25 | $3.4M | $411.4M | ||
| Q3 25 | — | $216.7M | ||
| Q2 25 | $-82.2M | $66.3M | ||
| Q1 25 | $32.5M | $22.6M | ||
| Q4 24 | — | $380.4M | ||
| Q3 24 | — | $187.7M | ||
| Q2 24 | $-49.9M | $72.7M | ||
| Q1 24 | — | $47.7M |
| Q4 25 | 1.2% | 208.5% | ||
| Q3 25 | — | 116.1% | ||
| Q2 25 | -29.6% | 31.0% | ||
| Q1 25 | 10.0% | 10.8% | ||
| Q4 24 | — | 182.5% | ||
| Q3 24 | — | 107.4% | ||
| Q2 24 | -16.3% | 36.9% | ||
| Q1 24 | — | 24.5% |
| Q4 25 | 1.8% | 19.3% | ||
| Q3 25 | — | 3.6% | ||
| Q2 25 | 3.3% | 5.3% | ||
| Q1 25 | 2.4% | 4.8% | ||
| Q4 24 | — | 21.8% | ||
| Q3 24 | — | 6.7% | ||
| Q2 24 | 3.3% | 6.8% | ||
| Q1 24 | — | 5.0% |
| Q4 25 | 4.21× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -0.16× | 1.42× | ||
| Q1 25 | 3.38× | 1.01× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 8.06× | ||
| Q2 24 | -1.54× | 2.11× | ||
| Q1 24 | — | 1.48× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
